☰

Roy H. Decker, Ph.D. - Publications

Affiliations: 
2001 Virginia Commonwealth University, Richmond, VA, United States 
Area:
Oncology, Molecular Biology
Tree Info Similar researchers PubMed Report error

198 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Saeed NA, Jin L, Amini A, Verma V, Lester-Coll NH, Chen PH, Decker RH, Park HS. Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer. American Journal of Clinical Oncology. 46: 66-72. PMID 36662872 DOI: 10.1097/COC.0000000000000974  0.434
2022 Saeed NA, Jin L, Sasse AW, Amini A, Verma V, Lester-Coll NH, Chen PH, Decker RH, Park HS. Hypofractionated standard radiotherapy for locally advanced limited-stage small cell lung cancer. Journal of Thoracic Disease. 14: 306-320. PMID 35280466 DOI: 10.21037/jtd-21-1566  0.382
2021 Raju SC, Peters GW, Decker RH, Park HS. Clinical Outcomes and Safety Profile in the Treatment of Synchronous Nonmetastatic Lung Tumors With Stereotactic Body Radiation Therapy. Practical Radiation Oncology. 12: e110-e116. PMID 34861443 DOI: 10.1016/j.prro.2021.11.006  0.371
2021 Jairam V, Pasha S, Soulos PR, Gross CP, Yu JB, Park HS, Decker RH. Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques. Lung Cancer (Amsterdam, Netherlands). 161: 171-179. PMID 34607209 DOI: 10.1016/j.lungcan.2021.09.010  0.37
2021 Saffarzadeh AG, Canavan M, Resio BJ, Walters SL, Flores KM, Decker RH, Boffa DJ. Optimal Radiation Dose for Stage III Lung Cancer-Should "Definitive" Radiation Doses Be Used in the Preoperative Setting? Jto Clinical and Research Reports. 2: 100201. PMID 34590044 DOI: 10.1016/j.jtocrr.2021.100201  0.309
2021 Argiris A, Miao J, Cristea MC, Chen AM, Sands JM, Decker RH, Gettinger SN, Daly ME, Faller BA, Albain KS, Yanagihara RH, Garland LL, Byers LA, Wang D, Koczywas M, et al. A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811). Clinical Lung Cancer. PMID 33745865 DOI: 10.1016/j.cllc.2021.02.009  0.334
2021 Daly ME, Ismaila N, Decker RH, Higgins K, Owen D, Saxena A, Franklin GE, Donaldson D, Schneider BJ. Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2003364. PMID 33502911 DOI: 10.1200/JCO.20.03364  0.365
2020 Jairam V, Park HS, Decker RH. Local Ablative Therapies for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer. Cancer Journal (Sudbury, Mass.). 26: 129-136. PMID 32205537 DOI: 10.1097/Ppo.0000000000000433  0.454
2020 Jabbour SK, Berman AT, Decker RH, Lin Y, Feigenberg SJ, Gettinger SN, Aggarwal C, Langer CJ, Simone CB, Bradley JD, Aisner J, Malhotra J. Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial. Jama Oncology. PMID 32077891 DOI: 10.1001/Jamaoncol.2019.6731  0.402
2020 Saeed NA, Kelly JR, Deshpande HA, Bhatia AK, Burtness BA, Judson BL, Mehra S, Edwards HA, Yarbrough WG, Peter PR, Holt EH, Decker RH, Husain ZA, Park HS. Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer. Head & Neck. PMID 32011055 DOI: 10.1002/Hed.26086  0.37
2020 Gao SJ, Decker RH. Contemporary Topics in Radiation Medicine: Skin Cancer. Hematology/Oncology Clinics of North America. 34: 189-203. PMID 31739944 DOI: 10.1016/J.Hoc.2019.09.008  0.383
2020 Yang DX, Jairam V, Park HS, Decker RH, Chiang AC, Gross CP, Yu JB. Use of prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer receiving immunotherapy. Journal of Clinical Oncology. 38: e19309-e19309. DOI: 10.1200/Jco.2020.38.15_Suppl.E19309  0.347
2020 Jabbour SK, Houghton B, Robinson AG, Quantin X, Wehler T, Kowalski D, Ahn M, Erman M, Giaccone G, Borghaei H, McLean J, Zhang J, Souza F, Decker R. Abstract CT288: Phase 3, randomized, placebo-controlled study of stereotactic body radiotherapy (SBRT) with or without pembrolizumab in patients with inoperable stage I/IIA non-small-cell lung cancer (NSCLC): KEYNOTE-867 Cancer Research. 80. DOI: 10.1158/1538-7445.Am2020-Ct288  0.465
2020 Chang E, Du J, Decker R, Yu J, Park H, Aneja S. Development and Validation of a Deep Learning Algorithm to Predict Radiation Pneumonitis and Esophagitis Following Lung Stereotactic Body Radiation Therapy International Journal of Radiation Oncology Biology Physics. 108. DOI: 10.1016/J.Ijrobp.2020.02.496  0.395
2020 Park H, Saeed N, Decker R. Utilization and Survival Impact of Definitive Hypofractionated Radiotherapy Compared to Conventionally Fractionated Radiotherapy in Stage I Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 108. DOI: 10.1016/J.Ijrobp.2020.02.494  0.487
2019 Decker RH, Blasberg JD. A new approach to predicting risk for N2 disease in non-small cell lung cancer. Journal of Thoracic Disease. 11: S1973-S1975. PMID 31632801 DOI: 10.21037/Jtd.2019.07.61  0.425
2019 Young MR, Decker RH. SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time. International Journal of Radiation Oncology, Biology, Physics. 105: 121-123. PMID 31422805 DOI: 10.1016/J.Ijrobp.2019.05.021  0.361
2019 Kann BH, Verma V, Stahl JM, Ross R, Dosoretz AP, Shafman TD, Gross CP, Park HS, Yu JB, Decker RH. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 134: 44-49. PMID 31005223 DOI: 10.1016/J.Radonc.2019.01.027  0.461
2019 Jabbour SK, Berman AT, Decker RH, Lin Y, Feigenberg SJ, Gettinger SN, Aggarwal C, Langer CJ, Simone CB, Bradley JD, Aisner J, Malhotra J. Prospective phase I multi-institutional trial of PD-1 blockade with pembrolizumab during concurrent chemoradiation for locally advanced, unresectable non-small cell lung cancer. Journal of Clinical Oncology. 37: 8511-8511. DOI: 10.1200/Jco.2019.37.15_Suppl.8511  0.352
2019 Yu J, Tsay C, Sasaki C, Son Y, Decker R, Mehra S, Burtness B. Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs Annals of Oncology. 30: v457. DOI: 10.1093/Annonc/Mdz252.019  0.411
2019 Miccio J, Johnson S, Jairam V, Yu J, Hansen J, Aneja S, An Y, Decker R, Omay S, Chiang V, Park H. Upfront Stereotactic Radiosurgery in the Treatment of Brain Metastasis from Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E81-E82. DOI: 10.1016/J.Ijrobp.2019.06.2348  0.407
2019 Gao S, Kann B, Dosoretz A, Shafman T, Gross C, Yu J, Decker R. An Externally Validated Nomogram to Predict Distant Metastases after Stereotactic Body Radiation Therapy in Early Stage Non-Small Cell Lung Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 105: S145-S146. DOI: 10.1016/J.Ijrobp.2019.06.146  0.514
2019 Chang E, Decker R, Hu X, Yu J, Gross C, Lester-Coll N. Predictors of Toxicity from Stereotactic Body Radiotherapy (SBRT) for Lung Tumors Ultra-Central or Central to Heart, Esophagus, or Proximal Bronchial Tree International Journal of Radiation Oncology*Biology*Physics. 105: E499-E500. DOI: 10.1016/J.Ijrobp.2019.06.1413  0.356
2018 Johung K, Kann B, Lacy J, Stein S, Kortmansky J, Zaheer W, Cheng Y, Lam W, Liu S, Decker R, Hochster H, Higgins S. Pilot trial of YIV-906 with neoadjuvant chemoradiotherapy (CRT) in patients with locally advanced rectal cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: v90. PMID 32177310 DOI: 10.1093/Annonc/Mdy151.319  0.379
2018 Kann BH, Miccio JA, Stahl JM, Ross R, Verma V, Dosoretz AP, Park HS, Shafman TD, Gross CP, Yu JB, Decker RH. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 30391106 DOI: 10.1016/J.Radonc.2018.10.017  0.461
2018 Hart GR, Roffman DA, Decker R, Deng J. A multi-parameterized artificial neural network for lung cancer risk prediction. Plos One. 13: e0205264. PMID 30356283 DOI: 10.1371/Journal.Pone.0205264  0.341
2018 Kalemkerian GP, Loo BW, Akerley W, Attia A, Bassetti M, Boumber Y, Decker R, Dobelbower MC, Dowlati A, Downey RJ, Florsheim C, Ganti AKP, Grecula JC, Gubens MA, Hann CL, et al. NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 1171-1182. PMID 30323087 DOI: 10.6004/Jnccn.2018.0079  0.445
2018 Kann BH, Aneja S, Loganadane GV, Kelly JR, Smith SM, Decker RH, Yu JB, Park HS, Yarbrough WG, Malhotra A, Burtness BA, Husain ZA. Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks. Scientific Reports. 8: 14036. PMID 30232350 DOI: 10.1038/S41598-018-32441-Y  0.306
2018 Johnson SB, Decker RH. Prophylactic Cranial Irradiation Versus Surveillance: Physician Bias and Patient-centered Decision-making. Clinical Lung Cancer. PMID 30201223 DOI: 10.1016/J.Cllc.2018.08.003  0.358
2018 Kelada OJ, Decker RH, Nath SK, Johung KL, Zheng MQ, Huang Y, Gallezot JD, Liu C, Carson RE, Oelfke U, Carlson DJ. High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors. International Journal of Radiation Oncology, Biology, Physics. 102: 174-183. PMID 30102194 DOI: 10.1016/J.Ijrobp.2018.05.032  0.446
2018 Breen W, Kelly J, Park HS, Son Y, Sasaki C, Wilson L, Decker R, Husain ZA. Permanent Interstitial Brachytherapy for Previously Irradiated Head and Neck Cancer. Cureus. 10: e2517. PMID 29942720 DOI: 10.7759/Cureus.2517  0.344
2018 Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Blitzblau R, Bowen GM, Contreras CM, Daniels GA, Decker R, Farma JM, Fisher K, Gastman B, Ghosh K, Grekin RC, et al. Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 742-774. PMID 29891526 DOI: 10.6004/Jnccn.2018.0055  0.356
2018 Shukla ND, Salahudeen AA, Taylor GA, Ramalingam SS, Vokes EE, Goss GD, Decker RH, Kelly K, Scagliotti GV, Mok TS, Wakelee HA. Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy. Clinical Lung Cancer. PMID 29653819 DOI: 10.1016/J.Cllc.2018.03.004  0.43
2018 Kelly JR, Park HS, An Y, Yarbrough WG, Contessa JN, Decker R, Mehra S, Judson BL, Burtness B, Husain Z. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer. Oral Oncology. 79: 64-70. PMID 29598952 DOI: 10.1016/J.Oraloncology.2018.02.017  0.349
2018 Goldberg SB, Narayan A, Kole AJ, Decker RH, Teysir J, Carriero NJ, Lee A, Nemati R, Nath SK, Mane SM, Deng Y, Sukumar N, Zelterman D, Boffa DJ, Politi K, et al. Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29330207 DOI: 10.1158/1078-0432.Ccr-17-1341  0.378
2018 Campbell AM, Herbst RS, Gettinger SN, Goldberg SB, Kluger HM, Chiang AC, Lilenbaum R, Schalper KA, Sowell RT, Kaech SM, Decker RH. Final results of a phase I prospective trial evaluating the combination of stereotactic body radiotherapy (SBRT) with concurrent pembrolizumab in patients with metastatic non-small cell lung cancer (NSCLC) or melanoma. Journal of Clinical Oncology. 36: 9099-9099. DOI: 10.1200/Jco.2018.36.15_Suppl.9099  0.384
2018 Saeed NA, Kelly JR, Deshpande H, Bhatia A, Burtness B, Judson BL, Mehra S, Osborn H, Yarbrough W, Peter PR, Holt EH, Decker RH, Husain ZA, Park HSM. Adjuvant External Beam Radiation Therapy for Surgically Resected, Non-Metastatic Anaplastic Thyroid Cancer International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.923  0.414
2018 Campbell A, Herbst R, Gettinger S, Goldberg S, Kluger H, Chiang A, Lilenbaum R, Schalper K, Sowell R, Kaech S, Decker R. Final Results of a Phase I Prospective Trial Evaluating the Combination of Stereotactic Body Radiation Therapy (SBRT) with Concurrent Pembrolizumab in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) or Melanoma International Journal of Radiation Oncology*Biology*Physics. 102: S18-S19. DOI: 10.1016/J.IJROBP.2018.06.134  0.403
2018 Kann B, Miccio J, Stahl J, Verma V, Dosoretz A, Park H, Shafman T, Gross C, Yu J, Decker R. Systemic Therapy with Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Non-Small Cell Lung Carcinoma (NSCLC): A Multi-institutional Analysis International Journal of Radiation Oncology*Biology*Physics. 102: S10-S11. DOI: 10.1016/J.Ijrobp.2018.06.119  0.465
2018 Johnson SB, Stahl JM, Miccio JA, Kann BH, Kelly JR, Decker R. (OA05) Stereotactic Body Radiation and Adjuvant Chemotherapy Versus Surgery and Adjuvant Chemotherapy For T1-2N0 Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 101: e2-e3. DOI: 10.1016/J.Ijrobp.2018.02.044  0.454
2017 Chowdhary M, Okwan-Duodu D, Switchenko JM, Press RH, Jhaveri J, Buchwald ZS, Zhong J, Chapman BV, Bindra RS, Contessa JN, Park HS, Yu JB, Decker RH, Olson JJ, Oyesiku NM, et al. Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery. Journal of Neuro-Oncology. PMID 29124649 DOI: 10.1007/S11060-017-2652-0  0.362
2017 Gao SJ, Kim AW, Puchalski JT, Bramley K, Detterbeck FC, Boffa DJ, Decker RH. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT. Lung Cancer (Amsterdam, Netherlands). 109: 36-41. PMID 28577947 DOI: 10.1016/J.Lungcan.2017.04.018  0.389
2017 Campbell AM, Decker RH. Mini-review of conventional and hypofractionated radiation therapy combined with immunotherapy for non-small cell lung cancer. Translational Lung Cancer Research. 6: 220-229. PMID 28529904 DOI: 10.21037/Tlcr.2017.03.02  0.445
2017 Bledsoe TJ, Park HS, Stahl JM, Yarbrough WG, Burtness BA, Decker RH, Husain ZA. Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival. Journal of the National Cancer Institute. 109. PMID 28521361 DOI: 10.1093/Jnci/Djx042  0.447
2017 An Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, Contessa JN, Decker RH, Koshy M, Husain ZA. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. PMID 28323338 DOI: 10.1002/Cncr.30598  0.348
2017 Verma V, Shostrom VK, Zhen W, Zhang M, Braunstein SE, Holland J, Hallemeier CL, Harkenrider MM, Iskhanian A, Jabbour SK, Attia A, Lee P, Wang K, Decker RH, McGarry RC, et al. Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis. International Journal of Radiation Oncology, Biology, Physics. 97: 778-785. PMID 28244414 DOI: 10.1016/J.Ijrobp.2016.11.049  0.475
2017 Kelly JR, Park HS, An Y, Contessa JN, Yarbrough WG, Burtness BA, Decker R, Husain Z. Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study. Jama Oncology. PMID 28056116 DOI: 10.1001/Jamaoncol.2016.5769  0.368
2017 Stahl JM, Corso CD, Verma V, Park HS, Nath SK, Husain ZA, Simone CB, Kim AW, Decker RH. Trends in stereotactic body radiation therapy for stage I small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 103: 11-16. PMID 28024690 DOI: 10.1016/J.Lungcan.2016.11.009  0.513
2017 Kann BH, Johung K, Cheng Y, Lam W, Liu S, Decker RH, Higgins SA. Pilot trial of KD018 with neo-adjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancer. Journal of Clinical Oncology. 35: e15162-e15162. DOI: 10.1200/Jco.2017.35.15_Suppl.E15162  0.397
2017 Goldberg S, Narayan A, Kole A, Decker R, Teysir J, Carriero N, Lee A, Nemati R, Nath S, Mane S, Deng Y, Sukumar N, Zelterman D, Boffa D, Politi K, et al. Assessing response to immunotherapy in patients with non-small cell lung cancer using circulating tumor DNA Annals of Oncology. 28: v478. DOI: 10.1093/Annonc/Mdx380.043  0.401
2017 Decker R, Goldberg S, Nath S, Husain Z, Lilenbaum R, Schalper K, Chiang A, Altan M, Zelterman D, Kaech S, Herbst R, Gettinger S. P3.02c-048 A Phase I/II Trial Evaluating the Combination of Stereotactic Body Radiotherapy and Pembrolizumab in Metastatic NSCLC Journal of Thoracic Oncology. 12: S1303-S1304. DOI: 10.1016/J.Jtho.2016.11.1843  0.306
2017 Johnson S, Kole A, Bledsoe T, Park H, Decker R. Adjuvant Radiation Therapy Improves Overall Survival After Margin-Positive Resection of Thymic Carcinoma International Journal of Radiation Oncology*Biology*Physics. 99: S211-S212. DOI: 10.1016/J.Ijrobp.2017.06.523  0.397
2017 Hayman T, Bledsoe T, Corso C, Lester-Coll N, Park H, Decker R. Increasing Utilization of Stereotactic Radiation Therapy as a Component of Initial Therapy in Metastatic Non–small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E459. DOI: 10.1016/J.Ijrobp.2017.06.1702  0.468
2017 Bui D, Magnuson W, Lester-Coll N, Qian J, Ross R, Soulos P, Shafman T, Dosoretz A, Evans S, Yu J, Gross C, Decker R. Stereotactic Body Radiation Therapy for Oligometastatic Disease: A Multi-Institutional Retrospective Survival Analysis International Journal of Radiation Oncology*Biology*Physics. 99: E443. DOI: 10.1016/J.Ijrobp.2017.06.1664  0.38
2017 Aneja S, Shaham U, Kumar R, Pirakitikulr N, Nath S, Yu J, Carlson D, Decker R. Deep Neural Network to Predict Local Failure Following Stereotactic Body Radiation Therapy: Integrating Imaging and Clinical Data to Predict Outcomes International Journal of Radiation Oncology*Biology*Physics. 99: S47. DOI: 10.1016/J.Ijrobp.2017.06.120  0.31
2017 Stahl JM, Corso CD, Verma V, Park HS, Nath SK, Husain ZA, Simone CB, Kim AW, Decker RH. P085) Trends in Stereotactic Body Radiation Therapy for Stage I Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 98. DOI: 10.1016/J.Ijrobp.2017.02.181  0.501
2017 Bledsoe TJ, Park HS, Stahl JM, Yarbrough WG, Burtness BA, Decker RH, Husain ZA. (S027) Hypofractionated Radiotherapy Is associated With Improved Overall Survival Among Patients With Early-Stage Glottic Cancer International Journal of Radiation Oncology*Biology*Physics. 98: E8-E9. DOI: 10.1016/J.Ijrobp.2017.02.063  0.406
2016 Park HS, Decker RH. Disparities in radiation therapy delivery: current evidence and future directions in head and neck cancer. Cancers of the Head & Neck. 1: 5. PMID 31093335 DOI: 10.1186/S41199-016-0005-X  0.421
2016 Verma V, Simone CB, Allen PK, Gajjar SR, Shah C, Zhen W, Harkenrider MM, Hallemeier CL, Jabbour SK, Matthiesen CL, Braunstein SE, Lee P, Dilling TJ, Allen BG, Nichols EM, ... ... Decker RH, et al. Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 28011047 DOI: 10.1016/J.Ijrobp.2016.10.041  0.506
2016 Gao SJ, Corso CD, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall. Clinical Lung Cancer. PMID 27890561 DOI: 10.1016/J.Cllc.2016.08.005  0.5
2016 Stahl JM, Ross R, Harder EM, Mancini BR, Soulos PR, Finkelstein SE, Shafman TD, Dosoretz AP, Evans SB, Husain ZA, Yu JB, Gross CP, Decker RH. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: 1011-1020. PMID 27869080 DOI: 10.1016/J.Ijrobp.2016.08.033  0.519
2016 Verma V, Shostrom VK, Kumar SS, Zhen W, Hallemeier CL, Braunstein SE, Holland J, Harkenrider MM, S Iskhanian A, Neboori HJ, Jabbour SK, Attia A, Lee P, Alite F, Walker JM, ... ... Decker RH, et al. Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors. Cancer. PMID 27741355 DOI: 10.1002/Cncr.30375  0.432
2016 Husain ZA, Chen T, Corso CD, Wang Z, Park H, Judson B, Yarbrough W, Deshpande H, Mehra S, Kuo P, Decker RH, Burtness BA. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma. Jama Oncology. PMID 27737449 DOI: 10.1001/Jamaoncol.2016.4581  0.341
2016 Gao SJ, Corso CD, Wang EH, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 27720827 DOI: 10.1016/J.Jtho.2016.09.122  0.476
2016 Gao S, Corso CD, Detterbeck FC, Boffa D, Decker RH, Kim AW. Effects of Adjuvant Therapy on Survival in T3N0 Non-Small Cell Lung Cancer Invading the Chest Wall. International Journal of Radiation Oncology, Biology, Physics. 96: S68-S69. PMID 27675990 DOI: 10.1016/J.Ijrobp.2016.06.175  0.47
2016 Park HS, Stahl JM, Lester-Coll NH, Rutter CE, Corso CD, Wang EH, Husain ZA, Decker RH, Yu JB, Wilson LD, Johung KL. Impact of Radiation Therapy Facility Case Volume on Survival in Anal Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S188. PMID 27675743 DOI: 10.1016/J.Ijrobp.2016.06.469  0.44
2016 Stahl JM, Ross R, Harder EM, Mancini BR, Soulos PR, Dosoretz AP, Finkelstein SE, Shafman TD, Husain ZA, Evans SB, Yu JB, Gross CP, Decker RH. A Biologically Effective Dose of ≥105 Gy Is Associated With Improved Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: S174-S175. PMID 27675708 DOI: 10.1016/J.Ijrobp.2016.06.438  0.524
2016 Gao S, Kim AW, Detterbeck FC, Boffa D, Puchalski J, Decker RH. Indications for Invasive Mediastinal Staging in Patients With Early Non-Small Cell Lung Cancer Staged With Positron Emission Tomography/Computed Tomography. International Journal of Radiation Oncology, Biology, Physics. 96: S11. PMID 27675547 DOI: 10.1016/J.Ijrobp.2016.06.041  0.394
2016 Bledsoe TJ, Rutter CE, Lester-Coll NH, Bi X, Decker RH. Radiation to Oligoprogessive Sites of Disease Can Prolong the Duration of Response to Immune Checkpoint Inhibitors in Patients With Metastatic Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E479. PMID 27674799 DOI: 10.1016/J.Ijrobp.2016.06.1832  0.446
2016 Park HS, Rutter CE, Lester-Coll NH, Corso CD, Wang EH, Wilson LD, Yu JB, Decker RH, Husain ZA. Facility Case Volume and Outcomes for Intensity Modulated Radiation Therapy in Head and Neck Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E325. PMID 27674384 DOI: 10.1016/J.Ijrobp.2016.06.1444  0.403
2016 Lester-Coll NH, Park HS, Rutter CE, Corso CD, Young MR, Ratner E, Litkouhi B, Decker RH, Yu JB, Damast S. Who Benefits From Chemoradiation in Locally Advanced Endometrial Cancer? An Analysis of the National Cancer Data Base. International Journal of Radiation Oncology, Biology, Physics. 96: E295. PMID 27674299 DOI: 10.1016/J.Ijrobp.2016.06.1366  0.374
2016 Mancini BR, Park HS, Harder EM, Rutter CE, Corso CD, Decker RH, Husain ZA. Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients. Lung Cancer (Amsterdam, Netherlands). 97: 22-7. PMID 27237023 DOI: 10.1016/J.Lungcan.2016.04.011  0.467
2016 Harder EM, Park HS, Chen ZJ, Decker RH. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy. Practical Radiation Oncology. PMID 27156424 DOI: 10.1016/J.Prro.2016.01.015  0.38
2016 Lester-Coll NH, Park HS, Rutter CE, Corso CD, Young MR, Ratner ES, Litkouhi B, Decker RH, Yu JB, Damast S. Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data Base. Gynecologic Oncology. PMID 27151429 DOI: 10.1016/J.Ygyno.2016.04.544  0.438
2016 Rosen JE, Salazar MC, Wang Z, Yu JB, Decker RH, Kim AW, Detterbeck FC, Boffa DJ. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. The Journal of Thoracic and Cardiovascular Surgery. PMID 27131846 DOI: 10.1016/J.Jtcvs.2016.03.060  0.456
2016 Argento AC, Decker R, Puchalski J. Fiducial Marker Placement Via Convex Probe EBUS. Journal of Bronchology & Interventional Pulmonology. 23: 181-5. PMID 27058722 DOI: 10.1097/Lbr.0000000000000217  0.402
2016 Lester-Coll NH, Rutter CE, Bledsoe TJ, Goldberg SB, Decker RH, Yu JB. Cost-Effectiveness of Surgery, Stereotactic Body Radiation Therapy, and Systemic Therapy for Pulmonary Oligometastases. International Journal of Radiation Oncology, Biology, Physics. PMID 27055395 DOI: 10.1016/J.Ijrobp.2016.01.020  0.333
2016 Husain ZA, Burtness BA, Decker RH. Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 396-8. PMID 26644528 DOI: 10.1200/Jco.2015.64.7586  0.389
2016 Cristea MC, Miao J, Argiris A, Chen AM, Daly ME, Decker RH, Garland LL, Wang D, Koczywas M, Moon J, Kelly K, Gandara DR. SWOG S1206: A dose-finding study of veliparib (ABT-888) added to chemoradiotherapy (CRT) with carboplatin (C) and paclitaxel (P) for unresectable stage III non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 34: 8537-8537. DOI: 10.1200/Jco.2016.34.15_Suppl.8537  0.443
2015 Wu AJ, Vapiwala N, Chmura SJ, Das P, Decker RH, Terezakis SA, Zietman AL. Taking "the Game" Out of The Match: A Simple Proposal. International Journal of Radiation Oncology, Biology, Physics. 93: 945-8. PMID 26581129 DOI: 10.1016/J.Ijrobp.2015.09.039  0.317
2015 Wang EH, Corso CD, Park HS, Chen AB, Wilson LD, Kim AW, Decker RH, Yu JB. Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. PMID 26523443 DOI: 10.1097/COC.0000000000000245  0.449
2015 Corso CD, Rutter CE, Park HS, Lester-Coll NH, Kim AW, Wilson LD, Husain ZA, Lilenbaum RC, Yu JB, Decker RH. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26481366 DOI: 10.1200/Jco.2015.62.4270  0.456
2015 Harder EM, Park HS, Nath SK, Mancini BR, Decker RH. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy. Practical Radiation Oncology. PMID 26412341 DOI: 10.1016/J.Prro.2015.07.003  0.358
2015 Rutter CE, Park HS, Corso CD, Yeboa DN, Mancini BR, Lester-Coll NH, Kim AW, Decker RH. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation. Lung Cancer (Amsterdam, Netherlands). PMID 26277031 DOI: 10.1016/J.Lungcan.2015.08.002  0.492
2015 Wang EH, Corso CD, Rutter CE, Park HS, Chen AB, Kim AW, Wilson LD, Decker RH, Yu JB. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26101240 DOI: 10.1200/JCO.2015.61.1517  0.485
2015 Corso CD, Park HS, Kim AW, Yu JB, Husain Z, Decker RH. Racial disparities in the use of SBRT for treating early-stage lung cancer. Lung Cancer (Amsterdam, Netherlands). 89: 133-8. PMID 26051446 DOI: 10.1016/J.Lungcan.2015.05.002  0.449
2015 Harder EM, Chen ZJ, Park HS, Mancini BR, Decker RH. Dose-Volume Predictors of Esophagitis After Thoracic Stereotactic Body Radiation Therapy. American Journal of Clinical Oncology. PMID 26017483 DOI: 10.1097/Coc.0000000000000195  0.338
2015 Husain ZA, Kim AW, Yu JB, Decker RH, Corso CD. Defining the High-Risk Population for Mortality After Resection of Early Stage NSCLC. Clinical Lung Cancer. PMID 25979646 DOI: 10.1016/J.Cllc.2015.04.007  0.385
2015 Yu JB, Soulos PR, Cramer LD, Decker RH, Kim AW, Gross CP. Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer. Cancer. 121: 2341-9. PMID 25847699 DOI: 10.1002/Cncr.29359  0.481
2015 Wang EH, Rutter CE, Corso CD, Decker RH, Wilson LD, Kim AW, Yu JB, Park HS. Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 937-43. PMID 25738221 DOI: 10.1097/Jto.0000000000000519  0.515
2015 Park HS, Harder EM, Mancini BR, Decker RH. Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 832-7. PMID 25634007 DOI: 10.1097/Jto.0000000000000484  0.461
2015 Colaco RJ, Decker RH. Stereotactic radiotherapy in the treatment of primary bronchial carcinoid tumor. Clinical Lung Cancer. 16: e11-4. PMID 25591327 DOI: 10.1016/J.Cllc.2014.12.005  0.366
2015 Park HS, Decker RH, Wilson LD, Yu JB. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases. Clinical Lung Cancer. 16: 292-7. PMID 25499149 DOI: 10.1016/J.Cllc.2014.11.005  0.446
2015 Corso CD, Rutter CE, Wilson LD, Kim AW, Decker RH, Husain ZA. Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 148-55. PMID 25325781 DOI: 10.1097/Jto.0000000000000406  0.503
2015 Combs SE, Hancock JG, Boffa DJ, Decker RH, Detterbeck FC, Kim AW. Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 316-23. PMID 25319182 DOI: 10.1097/Jto.0000000000000402  0.479
2015 Lester-Coll NH, Decker RH. The role of stereotactic body radiation therapy in the management of oligometastatic lung cancer Lung Cancer Management. 4: 145-153. DOI: 10.2217/Lmt.15.10  0.465
2015 Maroongroge S, Park HS, Rutter CE, Decker RH, Yu JB. Factors associated with high-volume providers of stereotactic radiation therapy for Medicare beneficiaries in 2012. Journal of Clinical Oncology. 33: e17578-e17578. DOI: 10.1200/Jco.2015.33.15_Suppl.E17578  0.373
2015 Su KW, Yu JB, Shafman T, Evans SB, Decker RH, Dosoretz A, Dosoretz DE, Ross R, Salenius S, Finkelstein SE, Hall J, Soulos PR, Gross CP. Changes in prostate cancer presentation for radiation oncology care after USPSTF recommendations, 2007-2013. Journal of Clinical Oncology. 33: e16070-e16070. DOI: 10.1200/Jco.2015.33.15_Suppl.E16070  0.362
2015 Park H, Wang E, Corso C, Rutter C, Wilson L, Kim A, Gross C, Yu J, Decker R. Higher Facility Case Volume of Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival in Clinical Stage I Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 93: S186-S187. DOI: 10.1016/J.Ijrobp.2015.07.447  0.507
2015 Corso C, Rutter C, Park H, Lester-Coll N, Husain Z, Decker R. The Role of Chemoradiation in Elderly Limited-Stage Small Cell Lung Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 93: S160-S161. DOI: 10.1016/J.Ijrobp.2015.07.384  0.46
2015 Park H, Corso C, Rutter C, Kim A, Yu J, Husain Z, Decker R. Survival Comparison of 3 Versus 4-5 Fractions for Stereotactic Body Radiation Therapy in Stage I Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 93: S100. DOI: 10.1016/J.Ijrobp.2015.07.240  0.522
2015 Harder EM, Park HSM, Chen Z, Decker RH. Pulmonary Dose Volume Predictors of Radiation Pneumonitis After Stereotactic Body Radiation Therapy International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1635  0.376
2015 Wang EH, Corso C, Park HSM, Chen AB, Kim AW, Wilson LD, Decker RH, Yu JB. Association Between Radiation Dose and Outcomes With Postoperative Radiation Therapy for N0-N1 Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1536  0.454
2014 Kelada O, Decker R, Zheng M, Huang Y, Xia Y, Gallezot J, Liu C, Rockwell S, Carson R, Oelfke U, Carlson D. WE-G-BRD-06: Variation in Dynamic Positron Emission Tomography Imaging of Tumor Hypoxia in Early Stage Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy. Medical Physics. 41: 520. PMID 28037065 DOI: 10.1118/1.4889490  0.389
2014 Corso CD, Park HS, Moreno AC, Kim AW, Yu JB, Husain ZA, Decker RH. Stage I Lung SBRT Clinical Practice Patterns. American Journal of Clinical Oncology. PMID 25503436 DOI: 10.1097/Coc.0000000000000162  0.485
2014 Kuo P, Chen MM, Decker RH, Yarbrough WG, Judson BL. Hypopharyngeal cancer incidence, treatment, and survival: temporal trends in the United States. The Laryngoscope. 124: 2064-9. PMID 25295351 DOI: 10.1002/Lary.24651  0.33
2014 Rutter CE, Corso CD, Park HS, Mancini BR, Yeboa DN, Lester-Coll NH, Kim AW, Decker RH. Increase in the use of lung stereotactic body radiotherapy without a preceding biopsy in the United States. Lung Cancer (Amsterdam, Netherlands). 85: 390-4. PMID 25001510 DOI: 10.1016/J.Lungcan.2014.06.013  0.454
2014 Moreno AC, Morgensztern D, Boffa DJ, Decker RH, Yu JB, Detterbeck FC, Wang Z, Rose MG, Kim AW. Treating locally advanced disease: an analysis of very large, hilar lymph node positive non-small cell lung cancer using the National Cancer Data Base. The Annals of Thoracic Surgery. 97: 1149-55. PMID 24582051 DOI: 10.1016/J.Athoracsur.2013.12.045  0.467
2014 Lloyd S, Dosoretz AP, Yu JB, Evans SB, Decker RH. Academic and Resident Radiation Oncologists' Attitudes and Intentions Regarding Radiation Therapy near the End of Life. American Journal of Clinical Oncology. PMID 24390273 DOI: 10.1097/Coc.0000000000000026  0.402
2014 Yu JB, Soulos PR, Cramer LD, Decker RH, Kim AW, Gross CP. Diffusion of stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) in the Medicare population, 2007-2009. Journal of Clinical Oncology. 32: 7575-7575. DOI: 10.1200/Jco.2014.32.15_Suppl.7575  0.395
2014 Lester-Coll N, Goldberg S, Yu J, Decker R. Cost Effectiveness Analysis of Stereotactic Body Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S58. DOI: 10.1016/J.Ijrobp.2014.08.271  0.474
2014 Husain Z, Kim A, Yu J, Decker R, Corso C. Predictors of 30-Day Mortality Following Resection of Early-Stage NSCLC: An Analysis of the National Cancer Data Base International Journal of Radiation Oncology*Biology*Physics. 90: S15. DOI: 10.1016/J.Ijrobp.2014.08.160  0.37
2014 Harder E, Park HS, Mancini BR, Decker RH. ACE Inhibitors Decrease the Risk of Radiation Pneumonitis Following SBRT: Early-Stage Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.08.154  0.476
2014 Mancini BR, Park HS, Harder E, Rutter CE, Corso CD, Decker RH, Husain ZA. Elderly Patients Undergoing SBRT for Inoperable Early-Stage NSCLC Achieve Similar Outcomes to Younger Patients: Early-Stage Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.08.149  0.438
2014 Corso C, Lloyd S, Harder E, Mancini B, Rutter C, Decker R. Invasive Mediastinal Staging Does Not Improve Outcomes Over PET Alone in Early-Stage NSCLC Treated With SBRT International Journal of Radiation Oncology*Biology*Physics. 90: S216-S217. DOI: 10.1016/J.Ijrobp.2014.05.790  0.33
2014 Corso C, Park H, Moreno A, Kim A, Husain Z, Yu J, Decker R. Trends in Stage I Lung SBRT Clinical Practice Patterns International Journal of Radiation Oncology*Biology*Physics. 90: S158-S159. DOI: 10.1016/J.Ijrobp.2014.05.647  0.348
2014 Yu J, Soulos P, Cramer L, Decker R, Kim A, Gross C. Comparative Effectiveness of Stereotactic Body Radiation Therapy Versus Surgery for Stage I Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S138. DOI: 10.1016/J.Ijrobp.2014.05.596  0.44
2014 Rutter C, Lester-Coll N, Yu J, Decker R. Cost Effectiveness of Biopsy Prior to Stereotactic Body Radiation Therapy (SBRT) for Screening-Detected FDG-Avid Lung Nodules International Journal of Radiation Oncology*Biology*Physics. 90: S137. DOI: 10.1016/J.Ijrobp.2014.05.593  0.389
2014 Husain Z, Kim A, Yu J, Decker R, Corso C. Predictors of 30-Day Mortality Following Resection of Early-Stage NSCLC: An Analysis of the National Cancer Database International Journal of Radiation Oncology*Biology*Physics. 90: S59. DOI: 10.1016/J.Ijrobp.2014.05.205  0.374
2014 Lloyd S, Dosoretz A, Yu J, Evans S, Decker R. Radiation Oncologists’ Opinions About Palliative Radiation Therapy for Patients on Hospice Care International Journal of Radiation Oncology*Biology*Physics. 90: S690. DOI: 10.1016/J.Ijrobp.2014.05.2027  0.362
2014 Harder E, Park H, Mancini B, Decker R. ACE Inhibitors Decrease the Risk of Radiation Pneumonitis Following SBRT International Journal of Radiation Oncology*Biology*Physics. 90: S13. DOI: 10.1016/J.Ijrobp.2014.05.1892  0.336
2014 Lester-Coll N, Decker R, Yu J. Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy for Pulmonary Oligometastases International Journal of Radiation Oncology*Biology*Physics. 90: S585-S586. DOI: 10.1016/J.Ijrobp.2014.05.1761  0.342
2014 Corso C, Park H, Moreno A, Kim A, Yu J, Husain Z, Decker R. Demographic Disparities in SBRT Utilization for Stage I NSCLC International Journal of Radiation Oncology*Biology*Physics. 90: S575. DOI: 10.1016/J.Ijrobp.2014.05.1734  0.35
2014 Park H, Harder E, Mancini B, Decker R. Does Central vs. Peripheral Tumor Location Impact Outcomes Following Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer? International Journal of Radiation Oncology*Biology*Physics. 90: S28-S29. DOI: 10.1016/J.Ijrobp.2014.05.132  0.434
2014 Kelada O, Decker R, Zheng M, Huang Y, Xia Y, Gallezot J, Liu C, Rockwell S, Carson R, Oelfke U, Carlson D. Serial Imaging of Tumor Hypoxia in Early Stage Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy International Journal of Radiation Oncology*Biology*Physics. 90: S26-S27. DOI: 10.1016/J.Ijrobp.2014.05.126  0.457
2013 Johung KL, Yao X, Li F, Yu JB, Gettinger SN, Goldberg S, Decker RH, Hess JA, Chiang VL, Contessa JN. A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5523-32. PMID 23897899 DOI: 10.1158/1078-0432.Ccr-13-0836  0.44
2013 Rosenzweig KE, Chang JY, Chetty IJ, Decker RH, Ginsburg ME, Kestin LL, Kong FM, Lally BE, Langer CJ, Movsas B, Videtic GM, Willers H. ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. Journal of the American College of Radiology : Jacr. 10: 654-64. PMID 23890874 DOI: 10.1016/J.Jacr.2013.05.031  0.501
2013 Lloyd S, Decker RH, Evans SB. Bone scan findings of chest wall pain syndrome after stereotactic body radiation therapy: implications for the pathophysiology of the syndrome. Journal of Thoracic Disease. 5: E41-4. PMID 23585956 DOI: 10.3978/J.Issn.2072-1439.2012.06.04  0.343
2013 Moreno AC, Morgensztern D, Yu JB, Boffa DJ, Decker RH, Detterbeck FC, Kim AW. Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database. The Journal of Surgical Research. 184: 10-8. PMID 23583079 DOI: 10.1016/J.Jss.2013.03.053  0.505
2013 Kuzmik GA, Detterbeck FC, Decker RH, Boffa DJ, Wang Z, Oliva IB, Kim AW. Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. 44: e66-70. PMID 23557918 DOI: 10.1093/Ejcts/Ezt184  0.472
2013 Kong FM, Lally BE, Chang JY, Chetty IJ, Decker RH, Ginsburg ME, Kestin LL, Langer CJ, Movsas B, Videtic GM, Willers H, Rosenzweig KE. ACR Appropriateness Criteria® radiation therapy for small-cell lung cancer. American Journal of Clinical Oncology. 36: 206-13. PMID 23511336 DOI: 10.1097/Coc.0B013E31827E5523  0.449
2013 Vest MT, Herrin J, Soulos PR, Decker RH, Tanoue L, Michaud G, Kim AW, Detterbeck F, Morgensztern D, Gross CP. Use of new treatment modalities for non-small cell lung cancer care in the Medicare population. Chest. 143: 429-35. PMID 23187634 DOI: 10.1378/Chest.12-1149  0.483
2013 Johung K, Rewari A, Wu H, Judson B, Contessa JN, Haffty BG, Decker RH. Role of excision repair cross-complementation 1 expression as a prognostic marker for response to radiotherapy in early-stage laryngeal cancer. Head & Neck. 35: 852-7. PMID 22740347 DOI: 10.1002/Hed.23041  0.362
2013 Lloyd S, Decker RH. Conference Scene: Notable trial results in radiation therapy for lung cancer at the ASCO 2013 Annual Meeting Lung Cancer Management. 2: 271-274. DOI: 10.2217/Lmt.13.33  0.503
2013 Moreno A, Morgensztern D, Yu J, Boffa D, Decker R, Detterbeck F, Kim A. Impact of Preoperative Radiation on Survival of Patients With Node Negative, Very Large Non-small Cell Lung Cancers (T3N0) Treated With Anatomic Resection Journal of Surgical Research. 179: 283. DOI: 10.1016/J.Jss.2012.10.554  0.484
2013 Lloyd S, Dosoretz A, Yu J, Evans S, Decker R. Radiation Oncologists’ Attitudes and Intentions Regarding Palliative Radiation Therapy Near the End of Life International Journal of Radiation Oncology*Biology*Physics. 87: S563. DOI: 10.1016/J.Ijrobp.2013.06.1493  0.359
2013 Mancini B, Giacalone N, Rutter C, Aneja S, Decker R, Husain Z. PET Predicts Survival Following Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 87: S11-S12. DOI: 10.1016/J.Ijrobp.2013.06.036  0.493
2012 Socinski MA, Stinchcombe TE, Moore DT, Gettinger SN, Decker RH, Petty WJ, Blackstock AW, Schwartz G, Lankford S, Khandani A, Morris DE. Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3953-9. PMID 23045594 DOI: 10.1200/Jco.2012.41.9820  0.422
2012 Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. Stereotactic body radiotherapy for central lung tumors. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 1394-9. PMID 22843088 DOI: 10.1097/Jto.0B013E3182614Bf3  0.364
2012 Kim AW, Detterbeck FC, Boffa DJ, Decker RH, Soulos PR, Cramer LD, Gross CP. Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer. The Annals of Thoracic Surgery. 94: 895-901. PMID 22835558 DOI: 10.1016/J.Athoracsur.2012.04.091  0.442
2012 Lloyd S, Park HS, Decker RH, Wilson LD, Yu JB. Using the Surveillance, Epidemiology, and End Results database to investigate rare cancers, second malignancies, and trends in epidemiology, treatment, and outcomes. Current Problems in Cancer. 36: 191-9. PMID 22495057 DOI: 10.1016/J.Currproblcancer.2012.03.008  0.325
2012 Yu JB, Soulos PR, Sharma R, Makarov DV, Decker RH, Smith BD, Desai RA, Cramer LD, Gross CP. Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics. 83: e101-7. PMID 22342095 DOI: 10.1016/J.Ijrobp.2011.11.067  0.415
2012 Decker RH, Lynch TJ. Unmet challenges in the use of novel agents in locally advanced non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 582-4. PMID 22271476 DOI: 10.1200/Jco.2011.40.1471  0.484
2012 Lloyd S, Yu JB, Wilson LD, Judson BL, Decker RH. The prognostic importance of midline involvement in oral tongue cancer. American Journal of Clinical Oncology. 35: 468-73. PMID 21701377 DOI: 10.1097/Coc.0B013E3182195619  0.31
2012 Baumgart MA, Acevedo-Gadea CR, Wang Z, Buta E, Davies M, Deshpande HA, Decker RH, Sasaki C, Judson B, Herbst RS, Morgensztern D. Influence of extracapsular extension on lymph node staging for patients with squamous cell carcinoma of the head and neck. Journal of Clinical Oncology. 30: 5532-5532. DOI: 10.1200/Jco.2012.30.15_Suppl.5532  0.304
2012 Acevedo-Gadea CR, Baumgart MA, Wang Z, Deshpande HA, Davies M, Decker RH, Sasaki C, Judson B, Herbst RS, Morgensztern D. Prognostic significance of the AJCC staging in patients with squamous cell carcinoma of the oropharynx. Journal of Clinical Oncology. 30: 5529-5529. DOI: 10.1200/Jco.2012.30.15_Suppl.5529  0.418
2012 Johung K, Yu J, Gettinger S, Decker R, Hess J, Chiang V, Contessa J. The Radiosensitivity of Tyrosine Kinase Driven Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S115. DOI: 10.1016/J.Ijrobp.2012.07.201  0.404
2012 Mancini B, Rowe B, Chang B, Decker R. Stereotactic Body Radiation Therapy for Patients With Clinically Versus Pathologically Diagnosed Non-small Cell Lung Cancer: A Comparative Analysis International Journal of Radiation Oncology*Biology*Physics. 84: S594. DOI: 10.1016/J.Ijrobp.2012.07.1584  0.504
2012 Mancini B, Rowe B, Chang B, Decker R. Comparative Analysis of Stereotactic Body Radiation Therapy for Multiple Primary Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S584-S585. DOI: 10.1016/J.Ijrobp.2012.07.1559  0.498
2011 Stinchcombe T, Socinski MA, Moore DT, Gettinger SN, Decker RH, Petty WJ, Blackstock AW, Schwartz G, Lankford S, Morris DE. Phase I/II trial of bevacizumab (B) and erlotinib (E) with induction (IND) and concurrent (CON) carboplatin (Cb)/paclitaxel (P) and 74 Gy of thoracic conformal radiotherapy (TCRT) in stage III non-small cell lung cancer (NSCLC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7016. PMID 28020077 DOI: 10.1200/Jco.2011.29.15_Suppl.7016  0.344
2011 Ross CC, Kim JJ, Chen ZJ, Grew DJ, Chang BW, Decker RH. A novel modified dynamic conformal arc technique for treatment of peripheral lung tumors using stereotactic body radiation therapy. Practical Radiation Oncology. 1: 126-34. PMID 24673926 DOI: 10.1016/J.Prro.2010.11.002  0.406
2011 Mehta HJ, Ross C, Silvestri GA, Decker RH. Evaluation and treatment of high-risk patients with early-stage lung cancer. Clinics in Chest Medicine. 32: 783-97. PMID 22054886 DOI: 10.1016/J.Ccm.2011.08.011  0.409
2011 Decker RH, Langer CJ, Rosenzweig KE, Chang JY, Gewanter RM, Ginsburg ME, Kong FM, Lally BE, Videtic GM, Movsas B. ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer. American Journal of Clinical Oncology. 34: 537-44. PMID 21946673 DOI: 10.1097/Coc.0B013E318216E5A2  0.503
2011 Chen ZJ, Roberts K, Decker R, Pathare P, Rockwell S, Nath R. The impact of prostate edema on cell survival and tumor control after permanent interstitial brachytherapy for early stage prostate cancers. Physics in Medicine and Biology. 56: 4895-912. PMID 21772076 DOI: 10.1088/0031-9155/56/15/016  0.333
2011 Aizer AA, Anderson NS, Oh SC, Yu JB, McKeon AM, Decker RH, Peschel RE. The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 79: 379-84. PMID 20452135 DOI: 10.1016/J.Ijrobp.2009.11.023  0.322
2011 Lloyd S, Yu JB, Wilson LD, Decker RH. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. American Journal of Clinical Oncology. 34: 76-81. PMID 20177363 DOI: 10.1097/Coc.0B013E3181D26D45  0.413
2011 Park H, Decker R, Wilson L, Yu J. Prophylactic Cranial Irradiation for High-Risk Patients with Locally Advanced Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 81: S627. DOI: 10.1016/J.Ijrobp.2011.06.1866  0.451
2011 Chen Z, Ye J, Su F, Kim J, Picone J, Kimmett J, Carlson D, Deng J, Nath R, Decker R. On the Use of 4DCT Derived Composite CT Images in the Planning of Stereotactic Body Radiotherapy (SBRT) for Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 81: S857. DOI: 10.1016/J.Ijrobp.2011.06.1524  0.33
2011 Decker R, Gettinger S, Glazer P, Wilson L. Vorinostat, a Histone Deacetylase Inhibitor, in Combination with Thoracic Radiotherapy in Advanced Non-small Cell Lung Cancer: A Dose Escalation Study International Journal of Radiation Oncology*Biology*Physics. 81: S574-S575. DOI: 10.1016/J.Ijrobp.2011.06.1074  0.438
2010 Gopal RS, Dubey S, Rosenzweig KE, Chang JY, Decker R, Gewanter RM, Kong FM, Lally BE, Langer CJ, Lee HK, Movsas B. ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung. International Journal of Radiation Oncology, Biology, Physics. 78: 969-74. PMID 20813465 DOI: 10.1016/J.Ijrobp.2010.07.028  0.444
2010 Gewanter RM, Rosenzweig KE, Chang JY, Decker R, Dubey S, Kong FM, Lally BE, Langer CJ, Lee HK, Movsas B. ACR Appropriateness Criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intent. Current Problems in Cancer. 34: 228-49. PMID 20541060 DOI: 10.1016/j.currproblcancer.2010.04.001  0.384
2010 Yu JB, Decker RH, Detterbeck FC, Wilson LD. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 215-9. PMID 20101146 DOI: 10.1097/Jto.0B013E3181Cd3208  0.431
2010 Lloyd S, Yu JB, Ross DA, Wilson LD, Decker RH. A prognostic index for predicting lymph node metastasis in minor salivary gland cancer. International Journal of Radiation Oncology, Biology, Physics. 76: 169-75. PMID 19386433 DOI: 10.1016/J.Ijrobp.2009.01.021  0.319
2010 Decker RH, Gettinger SN, Wilson LD. A dose-escalation study of vorinostat in combination with radiotherapy for patients with non-small cell lung cancer. Journal of Clinical Oncology. 28: TPS286-TPS286. DOI: 10.1200/Jco.2010.28.15_Suppl.Tps286  0.483
2010 Rewari A, Wu H, Contessa J, Haffty B, Decker R. Prognostic Value of p16 Expression in Laryngeal Cancer Patients Treated with Radiation International Journal of Radiation Oncology*Biology*Physics. 78: S64. DOI: 10.1016/J.Ijrobp.2010.07.181  0.38
2010 Johung KL, Rewari A, Wu H, Contessa J, Haffty B, Decker R. Role of Excision Repair Cross Complementation 1 Expression as a Prognostic Marker for Response to Radiotherapy in Early Stage Laryngeal Cancer International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.1544  0.355
2010 Yu J, Soulos P, Sharma R, Makarov D, Decker R, Smith B, Desai R, Cramer L, Gross C. Head and Neck Cancer (HNC) Patients Undergoing Primary Radiation with Intensity Modulated Radiation Therapy (IMRT) Demonstrate Improved Overall Survival (OS) Compared to Those Undergoing Conventional Radiation Therapy (CRT) in the SEER-Medicare Linked Database International Journal of Radiation Oncology*Biology*Physics. 78: S459. DOI: 10.1016/J.Ijrobp.2010.07.1077  0.445
2010 Gross C, Soulos P, Sharma R, Makarov D, Decker R, Smith B, Desai R, Cramer L, Yu J. Head and Neck Cancer (HNC) Patients Undergoing Intensity Modulated Radiation Therapy (IMRT) Have Fewer Subsequent Days of Hospitalization (DOH) than Do Patients Undergoing Conventional Radiation Therapy (CRT) in the SEER-Medicare Linked Database International Journal of Radiation Oncology*Biology*Physics. 78: S445. DOI: 10.1016/J.Ijrobp.2010.07.1045  0.42
2009 Galper SL, Deshpande H, Rose MG, Decker RH. Cetuximab versus cisplatin concurrent with IMRT in locally advanced head and neck cancer (LAHNC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e17030. PMID 27961805 DOI: 10.1200/Jco.2009.27.15_Suppl.E17030  0.411
2009 Aizer AA, Yu JB, Colberg JW, McKeon AM, Decker RH, Peschel RE. Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 93: 185-91. PMID 19800702 DOI: 10.1016/J.Radonc.2009.09.001  0.362
2009 Galper SL, Deshpande H, Rose MG, Colasanto J, Decker R. Accelerated Hypofractionated Radiation vs. Standard Fractionated Radiation Concurrent with Cetuximab Chemotherapy in Locally Advanced Head and Neck Cancer (LAHNC) International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.992  0.423
2009 Chamberlain D, Rowe B, Decker R. Simultaneous Treatment of Synchronous Primary Lung Cancers with Stereotactic Body Radiotherapy (SBRT) International Journal of Radiation Oncology*Biology*Physics. 75: S470. DOI: 10.1016/J.Ijrobp.2009.07.1072  0.434
2008 Yu JB, Decker RH, Knisely JP. The role of postoperative radiation therapy (PORT) in the treatment of extrahepatic bile duct cancer: a surveillance, epidemiology, and end results (SEER) population-based investigation. Journal of Gastrointestinal Cancer. 39: 11-21. PMID 19156542 DOI: 10.1007/S12029-008-9045-8  0.435
2008 Decker RH, Wilson LD. Postoperative radiation therapy for non-small cell lung cancer. Seminars in Thoracic and Cardiovascular Surgery. 20: 184-7. PMID 19038726 DOI: 10.1053/J.Semtcvs.2008.09.004  0.495
2008 Yu JB, Zelterman D, Decker RH, Knisely JP. Impact of immediate postoperative death on the estimation of a survival benefit from postoperative radiation therapy for cancer of the gallbladder. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4523; author reply 4. PMID 18802172 DOI: 10.1200/Jco.2008.17.4995  0.416
2008 Decker RH, Wilson LD. Advances in radiotherapy for lung cancer. Seminars in Respiratory and Critical Care Medicine. 29: 285-90. PMID 18506666 DOI: 10.1055/S-2008-1076748  0.505
2008 Galper S, Rowe B, Colasanto J, Fan Y, Haffty B, Dowsett R, Liggett P, Decker R. Outcomes after 125I Plaque Brachytherapy for Ocular Melanoma: The Yale Cancer Center Experience International Journal of Radiation Oncology*Biology*Physics. 72: S240. DOI: 10.1016/J.Ijrobp.2008.06.622  0.322
2008 Lawrence K, Picone J, Yang T, Trumpore S, Nath R, Decker R, Wilson L, Chen Z. Impact of Respiratory Motion on the Calculation of Lung Dose in Stereotactic Body Radiotherapy International Journal of Radiation Oncology*Biology*Physics. 72: S675-S676. DOI: 10.1016/J.Ijrobp.2008.06.385  0.344
2008 Chen Z, Deng J, Decker R, Roberts K, Wilson L, Nath R. Impact of using Different Tissue Heterogeneity Correction Algorithms on the Successful Implementation of Stereotactic Body Radiotherapy Programs for Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 72: S456-S457. DOI: 10.1016/J.Ijrobp.2008.06.1849  0.316
2008 Wilson L, Decker R, Yu J. Evaluation of the Role of Surgery in the Management of Limited/Early Stage (I-II) Small Cell Lung Cancer from the SEER database (1988-2004) International Journal of Radiation Oncology*Biology*Physics. 72: S448. DOI: 10.1016/J.Ijrobp.2008.06.1830  0.406
2008 Lloyd S, Wilson L, Decker R. Adjuvant Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck International Journal of Radiation Oncology*Biology*Physics. 72: S384-S385. DOI: 10.1016/J.Ijrobp.2008.06.1247  0.37
2008 Aizer AA, Yu JB, McKeon AM, Colberg JW, Concato JP, Decker RH, Peschel RE. Radical Prostatectomy versus Intensity Modulated Radiation Therapy in the Management of Localized Prostate Adenocarcinoma International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1119  0.337
2008 Anderson N, Patel R, Yu J, Peschel R, Decker R. A Significant Decrease in Rectal Volume and Diameter after 4500cGy during the Course of IMRT for Clinically Localized Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 72: S298-S299. DOI: 10.1016/J.Ijrobp.2008.06.1052  0.322
2007 Housman DM, Decker RH, Wilson LD. Regarding adjuvant radiation therapy in merkel cell carcinoma: selection bias and its affect on overall survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4503-4; author reply. PMID 17906216 DOI: 10.1200/Jco.2007.12.2895  0.399
2007 Colberg JW, Decker RH, Khan AM, McKeon A, Wilson LD, Peschel RE. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005. Cancer Journal (Sudbury, Mass.). 13: 229-32. PMID 17762756 DOI: 10.1097/Ppo.0B013E318046F14E  0.308
2007 Yang T, Lawrence K, Chen Z, Padmanabha S, Wilson L, Decker R. IMRT Allows Further Dose Escalation in Selected Patients With Stage III Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 69: S531. DOI: 10.1016/J.Ijrobp.2007.07.1768  0.463
2007 Knisely JPS, Decker RH, Yu JB. The Role of Postoperative Beam Radiation (PORT) in the Treatment of Extrahepatic Bile Duct Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Investigation International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.1332  0.353
2007 Chang B, Decker R, Haffty B, Knisely J. Incidence of Brain Metastases in Early-Stage Triple Negative Breast Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 69: S210-S211. DOI: 10.1016/J.Ijrobp.2007.07.1176  0.322
2006 Decker RH, Tanoue LT, Colasanto JM, Detterbeck FC, Wilson LD. Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities. Oncology (Williston Park, N.Y.). 20: 899-905; discussion . PMID 16922260  0.38
2006 Decker RH, Wilson LD. Role of radiotherapy in the management of merkel cell carcinoma of the skin. Journal of the National Comprehensive Cancer Network : Jnccn. 4: 713-8. PMID 16884673 DOI: 10.6004/Jnccn.2006.0061  0.349
2006 Decker RH, Tanoue LT, Colasanto JM, Detterbeck FC, Wilson LD. Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapy. Oncology (Williston Park, N.Y.). 20: 727-36. PMID 16841796  0.387
2003 Decker RH, Levin J, Kramer LB, Dai Y, Grant S. Enforced expression of the tumor suppressor p53 renders human leukemia cells (U937) more sensitive to 1-[beta-D-arabinofuranosyl]cytosine (ara-C)-induced apoptosis. Biochemical Pharmacology. 65: 1997-2008. PMID 12787880 DOI: 10.1016/S0006-2952(03)00149-7  0.348
2002 McKinstry R, Qiao L, Yacoub A, Dai Y, Decker R, Holt S, Hagan MP, Grant S, Dent P. Inhibitors of MEK1/2 interact with UCN-01 to induce apoptosis and reduce colony formation in mammary and prostate carcinoma cells. Cancer Biology & Therapy. 1: 243-53. PMID 12432271 DOI: 10.4161/Cbt.75  0.491
2002 Decker RH, Wang S, Dai Y, Dent P, Grant S. Loss of the Bcl-2 phosphorylation loop domain is required to protect human myeloid leukemia cells from flavopiridol-mediated mitochondrial damage and apoptosis. Cancer Biology & Therapy. 1: 136-44. PMID 12170773 DOI: 10.4161/Cbt.58  0.489
2001 Qiao L, Studer E, Leach K, McKinstry R, Gupta S, Decker R, Kukreja R, Valerie K, Nagarkatti P, El Deiry W, Molkentin J, Schmidt-Ullrich R, Fisher PB, Grant S, Hylemon PB, et al. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: Inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis Molecular Biology of the Cell. 12: 2629-2645. PMID 11553704 DOI: 10.1091/Mbc.12.9.2629  0.427
2001 Decker RH, Dai Y, Grant S. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway. Cell Death and Differentiation. 8: 715-24. PMID 11464216 DOI: 10.1038/sj.cdd.4400868  0.335
2001 Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cancer Research. 61: 2583-91. PMID 11289135  0.358
1999 Vrana JA, Decker RH, Johnson CR, Wang Z, Jarvis WD, Richon VM, Ehinger M, Fisher PB, Grant S. Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53. Oncogene. 18: 7016-25. PMID 10597302 DOI: 10.1038/Sj.Onc.1203176  0.343
Show low-probability matches.